what happens when you stop taking a glp 1 GLP-1 Medications? Outpatient Sedation Basics for Patients

Electrolyte Imbalance: Persistent diarrhea can cause electrolyte imbalances, disrupting normal blood and cardiovascular functions, potentially increasing clot risk

Protocol 2: the balanced approach (most common) Goal: Reduce side effects while reaching therapeutic doses in a reasonable timeframe Best for: First-time users, people who want a smoother experience than standard titration, those working with compounded formulations Complete schedule: Weeks 1-2: 0.25 mg weekly Weeks 3-4: 0.5 mg weekly Week 5: 1.0 mg weekly Weeks 6-7: 1.5 mg weekly Week 8-9: 2.0 mg weekly Weeks 10-13: 2.5 mg weekly Weeks 14-17: 5.0 mg weekly Time to therapeutic dose: 13-17 weeks Expected results: Mild GI effects at most transitions, noticeable appetite suppression by weeks 6-8, meaningful weight loss beginning around weeks 10-13 This is the protocol most practitioners recommend when patients specifically request microdosing

Bunck MC, Corner A, Eliasson B, et al

Tyna Moore, a naturopathic physician and chiropractor whos spent decades in regenerative medicine and metabolic health

The pancreatic safety (particularly with regard to acute pancreatitis) of incretin-based drugs such as GLP-1 receptor agonists has been discussed in recent years